Immunosuppressory activity of an isoxazolo[5,4-e]triazepine-compound RM-33 II. Effects on the carrageenan-induced inflammation

Pharmacological Reports

Volumn 58, Issue 2, 2006, Pages 236-241

  Zimecki, Michał ^a   Ryng, Stanisław ^b   Maczyński, Marcin ^b   Chodaczek, Grzegorz ^a   Kocieba, Maja ^a   Kuryszko, Jan ^c   Kaleta, Katarzyna ^c  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

Carrageenan; Isoxazolotriazepines; Rats; TNF

Indexed keywords

AZEPINE DERIVATIVE; CARRAGEENAN; ISOXAZOLO[5,4 E]TRIAZEPINE; MITOGENIC AGENT; RM 33; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CELL INFILTRATION; CELL ISOLATION; CELL STIMULATION; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FOOT EDEMA; FOOT PAD; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; MAST CELL; NONHUMAN; RAT; SKIN INFLAMMATION; SKIN MANIFESTATION; SPLEEN CELL; TREATMENT OUTCOME;

EID: 33646764942     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bianchi M, Rossoni G, Maggi R, Panerai AE, Berti F: Effects of carbamazepine on plasma extravasation and bronchoconstriction induced by substance P, capsaicin, acetaldehyde and histamine in guinea-pig lower airways. Fundam Clin Pharmacol, 1998, 12, 58-63.
2. De Resende MA, Pimenta Dos Rei WG, Pereira LS, Ferreira W, Perez Garcia MH, Santoro MM, Nogueira de Francischi J: Hyperalgesia and edema responses induced by rat peripheral blood mononuclear cells incubated with carrageenin. Inflammation, 2001, 25, 277-285.
3. Espevik T, Nissan-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human moonocytes. J Immunol Methods, 1986, 95, 99-105.
4. Esseffar M, Jalal R, El Messaoudi M, El Mouhtadi M: AM1 theoretical study on the mechanism of 1,3-dipolar cycloaddition reaction of 1,2,4-triazepine and formonitrile oxide. J Mol Structure: THEOCHEM, 1998, 433, 301-309.
5. Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods, 1989, 12, 203-210.
6. Huang WH, Yang CL, Lee AR, Chiu HF: Leflunomide analogues as potential antiinflammatory agents. Chem Pharm Bull (Tokyo), 2003, 51, 313-314.
7. Karalis K, Mastorakos G, Chrousos GP, Tolis G: Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest, 1994, 93, 2000-2006.
8. Lubetsky JB, Dios A, Han J, Aljabari B, Ruzsicska B, Mitchell R, Lolis E, Al-Abed Y: The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J Biol Chem, 2002, 277, 24976-24982.
9. Misiewicz B, Griebler C, Gomez M, Raybourne R, Zelazowska E, Gold PW, Sternberg EM: The estrogen antagonist tamoxifen inhibits carrageenan induced inflammation in LEW/N female rats. Life Sci, 1996, 58, 281-286.
10. Plescia S, Daidone G, Raffa D, Bajardi ML, Caruso A, Cutuli V, Amico-Roxas M: Synthesis and pharmacological study of some 3-(isoxazol-5-yl)-quinazolin-4(3H)-ones. Farmaco, 1992, 47, 465-475.
11. Reisner DB, Ludwig BJ, Simon E, Dejneka T, Sofia RD: 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino[3,2-b]quinazolin-10(2H)-ones. Arzneimittelforschung, 1977, 27, 766-770.
12. Rezessy B, Zubovics Z, Kovacs J, Toth G: Synthesis and structure elucidation of new thiazolotriazepines. Tetrahedron, 1999, 55, 5909-5922.
13. Ryng S, Zimecki M, Maczyński M, Chodaczek G, Kocieba M: Immunosuppressory activity of an isoxazolo[5,4-e]triazepine-compound RM-33. I. Effects on the humoral and cellular immune response in mice. Pharmacol Rep, 2005, 57, 195-202.
14. Sladowska H, Bodetko M, Sieklucka-Dziuba M, Rajtar G, Ziolkowska D, Kleinrok Z: Transformation of some pyrido[2,3-d]pyrimidine derivatives into other di- and triheterocyclic systems. Farmaco, 1997, 52, 657-662.
15. Tonussi CR, Ferreira SH: Tumour necrosis factor-alpha mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints. Pain, 1999, 82, 81-87.
16. Utsunomiya I, Nagai S, Oh-ishi S: Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J Immunol, 1991, 147, 1803-1809.
17. Verardo G, Toniutti N, Gorassini A, Giumanini AG: New heterocycles from the reaction between some natural α-amino acid hydrazides and formaldehyde. Eur J Org Chem, 1999, 11, 2943-2948.
18. Vinegar R, Truax JF, Selph JL, Johnston PR, Venable AL, McKenzie KK: Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed Proc, 1987, 46, 118-126.
19. Zimecki M, Miedzybrodzki R, Szymaniec S: Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch Immunol Ther Exp, 1998, 46, 361-365.